
Shares of pot firm Aurora Cannabis ACB.TO soar 41% to C$7.45
Co posts Q3 profit compared to a year-ago-loss, helped by strong performance at its global medical cannabis business
Posts Q3 net income from continuing operations of $31.2 mln compared to a year-ago loss of $17.1 mln
ACB's Q3 revenue rises to $88.2 mln from $64.4 mln last year; medical cannabis revenue increases 51% to $68.1 mln in Q3
TD Cowen analysts say the results show ACB's focus both outside of the U.S. and the international medical cannabis market is profitable
"ACB has turned over a proverbial new leaf following the reset in the cannabis industry, now with a focus on responsible growth," - TD Cowen
Co says it is now generating positive free cash flow of $27.4 mln in Q3 compared to negative FCF last year
In 2024, ACB stock fell 6% in 2024